JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB136633

Anti-EBV Latent Membrane Protein 1 antibody [D24-G]

Be the first to review this product! Submit a review

|

(6 Publications)

Rabbit Monoclonal EBV Latent Membrane Protein 1 antibody. Suitable for IHC-P and reacts with Epstein-Barr virus samples. Cited in 6 publications.

View Alternative Names

BNLF1, LMP1, Latent membrane protein 1, LMP-1, Protein p63

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EBV Latent Membrane Protein 1 antibody [D24-G] (AB136633)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EBV Latent Membrane Protein 1 antibody [D24-G] (AB136633)

Immunohistochemical analysis of Formalin-fixed, Paraffin-embedded Human lymph node tissue corresponding to EBV infectious mononucleosis labelling EBV Latent Membrane Protein with ab136633 antibody at 1/100 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EBV Latent Membrane Protein 1 antibody [D24-G] (AB136633)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EBV Latent Membrane Protein 1 antibody [D24-G] (AB136633)

Immunohistochemical analysis of Formalin-fixed, Paraffin-embedded Human lymph node tissue corresponding to Hodgkin’s lymphoma labelling EBV Latent Membrane Protein with ab136633 antibody at 1/100 dilution.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

D24-G

Isotype

IgG

Carrier free

No

Reacts with

Epstein-Barr virus

Applications

IHC-P

applications

Epitope

Antibody recognizes the epitope located between Asp293 - Asp312

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Epstein-Barr virus": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/200", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol." } } }

Properties and storage information

Form
Liquid
Purification notes
This immunoglobulin is the product of one single B-cell line from the crude anti-peptide polyclonal anti-serum. This antibody is purified using a propriety technique and offers a completely post-translationally modified and properly glycosylated antibody. This offers increased stability.
Storage buffer
pH: 8 Preservative: 0.05% Sodium azide Constituents: 2% BSA, 0.32% Tris HCl
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

EBV Latent Membrane Protein 1 also known as LMP1 is an important oncoprotein of Epstein-Barr virus (EBV). It acts mechanically to modulate cellular signaling pathways. LMP1 weighs approximately 63 kDa. This protein is highly expressed on the surface of lymphocytes and epithelial cells during latent EBV infection. LMP1 comprises several functional domains including Cytoplasmic Tail 1 (CS1) Cytoplasmic Tail 2 (CS2) and Cytoplasmic Tail 3 (CS3). Researchers often study its presence through methods like LMP1 immunohistochemistry (IHC)
Biological function summary

The protein plays a role in cellular transformation and proliferation acting as a mimic of CD40 receptor signaling. Within cells LMP1 aggregates to form oligomeric complexes that actively recruit TRAF and TRADD adapter proteins. This aggregation leads to the activation of NF-κB signaling and the MAPK pathways contributing to increased cell survival and proliferation. LMP1 functions as a major factor in sustaining EBV latency in infected cells and is essential for the virus's oncogenic potential.

Pathways

LMP1 is an integral component of the NF-κB and AP-1 signaling pathways. By engaging with the host cell machinery LMP1 recruits proteins such as IκB kinase complexes leading to the nuclear translocation of NF-κB transcription factors. This results in the transcription of genes related to cell growth and inflammation. LMP1 also interacts with p38 MAPK further enhancing pathways that contribute to EBV’s ability to foster an environment suitable for its persistence and propagation within the host.

LMP1 has strong associations with various malignancies especially nasopharyngeal carcinoma and Hodgkin's lymphoma. The protein’s role in disrupting normal cellular function relates it closely to the pathology of these cancers. It affects the expression of other proteins like c-Myc and Bcl-2 which are often found altered in malignancy. EBV antibodies particularly those targeting LMP1 are used to study the presence and progression of these diseases in infected individuals.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Acts as a CD40 functional homolog to prevent apoptosis of infected B-lymphocytes and drive their proliferation. Functions as a constitutively active tumor necrosis factor receptor that induces the activation of several signaling pathways, including those of the NF-kappa-B family. LMP1 signaling leads to up-regulation of antiapoptotic proteins and provide growth signals in latently infected cells. Interacts with host UBE2I and subsequently affects the sumoylation state of several cellular proteins. For example, induces the sumoylation of host IRF7 thereby limiting its transcriptional activity and modulating the activation of innate immune responses. Also inhibits host IFN-alpha-stimulated STAT2 nuclear translocation and interferon-stimulated response element transcriptional activity by interacting with and inhibiting host TYK2. Induces SUMO expression during viral latency thereby dysregulating the host sumoylation processes.
See full target information LMP1

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

PLoS pathogens 21:e1013410 PubMed40773523

2025

E2F1 suppresses Epstein-Barr virus lytic reactivation through cellular and viral transcriptional networks.

Applications

Unspecified application

Species

Unspecified reactive species

Joyanta Biswas,Sk Asif Ali,Samaresh Malik,Subhadeep Nag,Piyali Mukherjee,Abhik Saha

PLoS pathogens 20:e1011998 PubMed38530845

2024

Differential carbonic anhydrase activities control EBV-induced B-cell transformation and lytic cycle reactivation.

Applications

Unspecified application

Species

Unspecified reactive species

Samaresh Malik,Joyanta Biswas,Purandar Sarkar,Subhadeep Nag,Chandrima Gain,Shatadru Ghosh Roy,Bireswar Bhattacharya,Dipanjan Ghosh,Abhik Saha

Neural regeneration research 17:1023-1033 PubMed34558529

2021

Nerve bundle formation during the promotion of peripheral nerve regeneration: collagen VI-neural cell adhesion molecule 1 interaction.

Applications

Unspecified application

Species

Unspecified reactive species

Jia-Hui Sun,Ming Huang,Zhou Fang,Tian-Xiao Li,Ting-Ting Wu,Yi Chen,Da-Ping Quan,Ying-Ying Xu,Yu-Ming Wang,Yi Yang,Jian-Long Zou

Antiviral research 188:105038 PubMed33577806

2021

Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.

Applications

Unspecified application

Species

Unspecified reactive species

Peter Garcia,Abigail Harrod,Shruti Jha,Jessica Jenkins,Alex Barnhill,Holden Lee,Merritt Thompson,Jordan Pringle Williams,James Barefield,Ashton Mckinnon,Persia Suarez,Ananya Shah,Angela J Lowrey,Gretchen L Bentz

PLoS pathogens 16:e1008105 PubMed32092124

2020

Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chandrima Gain,Samaresh Malik,Shaoni Bhattacharjee,Arijit Ghosh,Erle S Robertson,Benu Brata Das,Abhik Saha

PLoS pathogens 15:e1008030 PubMed31518366

2019

Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival.

Applications

Unspecified application

Species

Unspecified reactive species

Liang Wei Wang,Zhonghao Wang,Ina Ersing,Luis Nobre,Rui Guo,Sizun Jiang,Stephen Trudeau,Bo Zhao,Michael P Weekes,Benjamin E Gewurz
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com